Genetically Engineered IL12/CSF1R‐Macrophage Membrane‐Liposome Hybrid Nanovesicles for NIR‐II Fluorescence Imaging‐Guided and Membrane‐Targeted Mild Photothermal‐Immunotherapy of Glioblastoma

Genetically Engineered IL12/CSF1R‐Macrophage Membrane‐Liposome Hybrid Nanovesicles for NIR‐II Fluorescence Imaging‐Guided and Membrane‐Targeted Mild Photothermal‐Immunotherapy of Glioblastoma

Abstract It is a big challenge for precision therapy of glioblastoma, mainly due to the existence of blood–brain barrier (BBB), tumor immunosuppressive microenvironment (TIM), and lack of efficient treatment paradigms. Herein, a theranostic nanoplatform for the second near‐infrared window (NIR‐II) f...

Full description

Saved in:
Bibliographic Details
Main Authors: Pengfei Chen, Yue Liu, Haiyan Huang, Menglong Li, Hui Xie, Shubham Roy, Jingsi Gu, Jian Jin, Kai Deng, Lixin Du, Bing Guo
Format: Article
Language:English
Published: Wiley 2025-06-01
Series:Advanced Science
Subjects:
biomimetic strategy
glioblastoma
immunotherapy
NIR‐II fluorescence imaging
photothermal therapy
Online Access:https://doi.org/10.1002/advs.202500131
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract It is a big challenge for precision therapy of glioblastoma, mainly due to the existence of blood–brain barrier (BBB), tumor immunosuppressive microenvironment (TIM), and lack of efficient treatment paradigms. Herein, a theranostic nanoplatform for the second near‐infrared window (NIR‐II) fluorescence imaging‐guided membrane‐targeted mild photothermal‐immunotherapy of glioblastoma using genetically engineered CSF1R/IL12‐macrophage membrane (MM)‐liposome hybrid nanovesicles, is reported. By mimicking lipophilic membrane probe (Dil) with octadecyl chains, a NIR‐II emissive photothermal dye (IRC18), which realizes labeling of nanovesicle lipid bilayers for biodistribution tracing, glioblastoma diagnosis, and molecular imaging of tumoral microenvironment, is synthesized. Importantly, MM and c‐RGD‐decorated liposome together offer BBB crossing, tumor targeting, and long‐term circulation; while, the genetically overexpressed CSF1R and IL12 on MM surface contribute to effective modulation of M2‐to‐M1 macrophage repolarization and local promotion of T cell cytotoxicity in glioblastoma microenvironment, respectively. Notably, through membrane fusion, IRC18 dyes translocate from nanovesicle lipid bilayers to glioblastoma membranes, which achieve membrane‐targeted mild photothermal therapy to ablate primary tumor and induce immunogenic cell death to promote antigen presentation. More importantly, the combined blockade of the CSF1‐CSF1R axis and IL‐12 enrichment not only reprograms the tumor microenvironment through macrophage M1 repolarization but also activates cytotoxic T cells, ultimately achieving complete glioblastoma eradication. This research provides an efficient theranostic paradigm for glioblastoma treatment.
ISSN:2198-3844

Similar Items